![J. J. Kang](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
J. J. Kang
Direktor/Vorstandsmitglied bei Exonics Therapeutics, Inc.
Aktive Positionen von J. J. Kang
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Exonics Therapeutics, Inc.
![]() Exonics Therapeutics, Inc. BiotechnologyHealth Technology Exonics Therapeutics, Inc. develops therapies for neuromuscular diseases. It also develops gene editing technologies like CRISPR/Cas9 to permanently correct the majority of duchenne muscular dystrophy mutations. The company was founded by Eric N. Olson in February 2017 and is headquartered in Cambridge, MA. | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von J. J. Kang
Statistik
International
Vereinigte Staaten | 2 |
Operativ
Director/Board Member | 1 |
Sektoral
Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
Exonics Therapeutics, Inc.
![]() Exonics Therapeutics, Inc. BiotechnologyHealth Technology Exonics Therapeutics, Inc. develops therapies for neuromuscular diseases. It also develops gene editing technologies like CRISPR/Cas9 to permanently correct the majority of duchenne muscular dystrophy mutations. The company was founded by Eric N. Olson in February 2017 and is headquartered in Cambridge, MA. | Health Technology |
- Börse
- Insiders
- J. J. Kang
- Erfahrung